PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19182950-0	2009	Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells.	Ginsenosides	37-48	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	92-96	
21971952-0	2012	Ginsenoside Re lowers blood glucose and lipid levels via activation             of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice.	Ginsenosides	0-11	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	83-111	
21971952-8	2012	In conclusion, the current study suggest that ginsenoside Re improves hyperglycemia and hyperlipidemia through activation of AMPK, and confers beneficial effects on type 2 diabetic patients with insulin resistance and dyslipidemia.	Ginsenosides	46-57	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	125-129	
20118562-0	2010	Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells.	Ginsenosides	0-11	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	58-86	
31467529-0	2019	Ginsenoside Rg1 Ameliorates Palmitic Acid-Induced Hepatic Steatosis and Inflammation in HepG2 Cells via the AMPK/NF-kappaB Pathway.	Ginsenosides	0-11	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	108-112	
35150861-0	2022	Ginsenoside Rd ameliorates high glucose-induced retinal endothelial injury through AMPK-STRT1 interdependence.	Ginsenosides	0-11	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	83-87	
35018944-9	2022	Mechanically, ginsenoside CK modulated the expression of factors correlated with lipid synthesis and metabolism in vitro and in vivo via activating the phosphorylation of LKB1 and AMPK.	Ginsenosides	14-25	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	180-184	
35018944-11	2022	In summary, ginsenoside CK acts as a LKB1/AMPK agonist to regulate the lipid metabolism and interfere with the progression of NAFLD.	Ginsenosides	12-23	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	42-46	
30475650-0	2019	Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways.	Ginsenosides	0-11	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	106-110	
29324976-0	2018	Ginsenoside Rg1 inhibits apoptosis by increasing autophagy via the AMPK/mTOR signaling in serum deprivation macrophages.	Ginsenosides	0-11	protein kinase AMP-activated catalytic subunit alpha 1	Homo sapiens	67-71